Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

NCT06374914 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

NCT NCT06374914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06374914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients
Lead sponsor
Dokuz Eylul University
Phase
Observational
Overall status
Unknown status
Start date
April 9, 2024
Completion date
April 9, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcg, bladder cancer, docetaxel, gemcitabine, intravesical instillation